Antibiotic therapy of the CAP at young patients from different social groups

H. V. Demchuk, Y. M. Mostovoy (Vinnytsia, Ukraine)

Source: Annual Congress 2003 - Severe pulmonary infection and sepsis
Session: Severe pulmonary infection and sepsis
Session type: Thematic Poster Session
Number: 2865
Disease area: Respiratory critical care, Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. V. Demchuk, Y. M. Mostovoy (Vinnytsia, Ukraine). Antibiotic therapy of the CAP at young patients from different social groups. Eur Respir J 2003; 22: Suppl. 45, 2865

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Antibiotic usage analysis of the community-acquired pneumonia at young patients from different social groups
Source: Eur Respir J 2003; 22: Suppl. 45, 149s
Year: 2003

Barriers to an early switch from intravenous to oral antibiotic therapy in hospitalised patients with CAP
Source: Eur Respir J 2013; 41: 123-130
Year: 2013



Therapeutic regimens in community acquired pneumonia (CAP): association with patients characteristics and outcomes
Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests
Year: 2008


Antimicrobial Treatment of CAP. Is there a higher benefit of macrolides combination in patients with pneumococcal CAP?
Source: International Congress 2017 – Update on community acquired pneumonia
Year: 2017




Influence of adherence to clinical guidelines in empiric antibiotics choice on outcomes of community-acquired pneumonia in hospitalized Belarussian patients
Source: Eur Respir J 2005; 26: Suppl. 49, 637s
Year: 2005

Patients‘ characteristics do not influence duration of antibiotic therapy (ABT) in hospitalized patients with community-acquired pneumonia (CAP): results from the CAPO international study
Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia
Year: 2008


Antibiotic use in special populations: renal failure and the obese patient
Source: Annual Congress 2013 –PG9 How to optimise antibiotic use in respiratory infections
Year: 2013

Antibiotic use in children with asthma
Source: International Congress 2017 – Small airways, long distances and large databases in paediatric asthma
Year: 2017



Trends in empiric antimicrobial therapy and efficiency of care for community-acquired pneumonia in hospitalized Belarussian patients
Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia
Year: 2007


Preventive chemotherapy effectiveness in children and adolescents, contacting TB patients with DR TB strains
Source: Eur Respir J 2006; 28: Suppl. 50, 536s
Year: 2006

Optimising decision for antibiotic treatment in non-hospitalised CAP patient
Source: Virtual Congress 2020 – Antibiotic resistance: the way forward
Year: 2020


Changes in empirical initial antibiotic therapy in community-acquired pneumonia: assessment of clinical failure versus discordant therapy
Source: Eur Respir J 2006; 28: Suppl. 50, 736s
Year: 2006

Antibiotic preferences for childhood pneumonia vary by physician type and European region
Source: ERJ Open Res 2016: 00001-2016
Year: 2016



Effectiveness of treatment for MDR TB in children and adolescents
Source: Annual Congress 2007 - Specific problems in caring for multidrug-resistant tuberculosis and tuberculosis/HIV cases
Year: 2007


Is tuberculosis different in elderly patients?
Source: Annual Congress 2007 - Epidemiology of tuberculosis II
Year: 2007


Empirical antibiotic management of adult CAP
Source: Eur Respir Monogr 2014; 63: 140-154
Year: 2014


The effectiveness of MDR TB treatment in children and adolescents depending on its duration
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology II
Year: 2012

Comparison of treatment outcomes in community-acquired pneumonia patients treated with beta lactam-macrolide combination versus fluoroquinolone monotherapy
Source: Annual Congress 2012 - Management of severe respiratory infections
Year: 2012

Costs of treatment of hospitalised community-acquired pneumonia from the hospitals’ perspective – a prospective study comparing moxifloxacin with other antibiotic treatment alternatives
Source: Eur Respir J 2004; 24: Suppl. 48, 185s
Year: 2004

The usage of laferon in treatment of patients with community acquired pneumonia (CAP)
Source: Eur Respir J 2007; 30: Suppl. 51, 675s
Year: 2007